Welcome : Guest

STAR Pharmaceutical Ltd. (Singapore) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about STAR Pharmaceutical Ltd., which is principally involved in Pharmaceuticals Business. Illustrated with 17 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-43382
Price: $850
Company Type: Public
Pages: 19
Date: November 2016
Market Data Tables: 17

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: STAR Pharmaceutical Ltd.'s Sales by Product Segment (2014-2015) in Percentage for Antibiotics, Cardiovascular Drugs and Cerebrovascular Drugs, and Other Specialised Drugs......3
Table 2: Star Pharmaceutical Ltd.’s Revenues by Category (2014) in Percentage for Sale of Antibiotics, Sale of Cardiovascular Drugs and Cerebrovascular Drugs and Sale of Other Specialised Drugs......4
Antibiotics......5
Table 3: Antibiotics Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......5
Table 4: Methicillin-Resistant Staphylococcus Aureus (MRSA) Antibiotics Market by Product Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cubicin, Tygacil, Vancocin (Generic), Vibativ (Telavancin), and Zyvox......6
Table 5: Antibiotics Market by Category in China (2015) - Percentage Share Breakdown by Value Sales for Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......7
Table 6: Antibiotic Market by Drug Type in the US (2015) - Percentage Share Breakdown by Podiatrists Prescription for Cephalosporins, Macrolides, Penicillins, Quinolones, and Tetracyclines......8
Table 7: Branded Acute Bacterial Skin and Skin Structure Infection Antibiotic Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Cubicin (Daptomycin), Teflaro (Ceftaroline), Tygacil (Tigecycline), and Zyvox (Linezolid)......9
Table 8: Branded Community-Acquired Bacterial Pneumonia Antibiotic Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Teflaro (Ceftaroline), Tygacil (Tigecycline), and Zyvox (Linezolid)......10
Generic Drugs......11
Table 9: Generics Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, India, North America, Russia and Other CIS and Rest of the World......11
Table 10: Generic Pharmaceuticals Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Diabetes, Hormonal Drugs, Oncology, Respiratory, Rheumatology, and Others......12
Special Treatment Drugs......13
Table 11: Special Treatment Drugs Market by Group in Vietnam (2015) - Percentage Share Breakdown by Value for Cardiovascular Group, Metabolism Group, Neurology, Sterilization Group and Others......13
Cardio-Cerebral Vascular (CCV) Drugs......14
Table 12: Market Shares of Leading Cardio-Cerebral Vascular (CCV) Drugs Manufacturers in China (2015) - Percentage Share Breakdown by Value for Sihuan Pharmaceutical Holdings Group Ltd., Sanofi S.A., Qilu pharmaceutical Co., Ltd. and Others......14
Prescription Pharmaceuticals......15
Table 13: Market Shares of Leading Prescription Pharmaceutical Companies in Indonesia (2015) - Percentage Breakdown by Volume Sales for Dexa Medica Group, Interbat Pharmaceutical Industry PT, PT Kalbe Farma, Tbk, PT Sanbe Farma, and Others......15
Table 14: Market Shares of Leading RX Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Eurofarma Laboratórios, Hypermarcas S.A.,Pfizer, Inc., Roche AG, Sanofi - Medley Indústria Farmacêutica Ltda and Others......16
Table 15: Market Shares of Leading Prescription Pharmaceutical Companies in the US (2014) - Percentage Market Share Breakdown by Volume Sales for Actavis Plc, Amneal, Inc., Endo Pharma, Inc., Lupin Pharmaceuticals, Inc., Mylan Labs,Inc., Novartis International AG, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and Others......17
Table 16: Market Shares of Leading Prescription Drug Companies in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries, Ltd., and Others......18
Table 17: Market Shares of Leading Prescription Drug Companies Spending through Media Ads in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......19